Literature DB >> 2188562

Beta 2-microglobulin: its significance and clinical usefulness.

M Bethea1, D T Forman.   

Abstract

beta 2-Microglobulin (beta 2M), an interesting and underutilized metabolite, can be used in assessing renal function, particularly in kidney-transplant recipients and in patients suspected of having renal tubulointerstitial disease. It also can serve as a nonspecific but relatively sensitive marker of various neoplastic, inflammatory, and infectious conditions. Early hopes that it would be a useful serum test for malignancy have not been fulfilled, but it does have prognostic value for patients with lymphoproliferative disease, particularly multiple myeloma. More recent reports have suggested a role for beta 2M as a prognostic marker in human immunodeficiency virus (HIV) infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2188562

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  28 in total

Review 1.  Biomarkers of Drug-Induced Kidney Toxicity.

Authors:  Benjamin R Griffin; Sarah Faubel; Charles L Edelstein
Journal:  Ther Drug Monit       Date:  2019-04       Impact factor: 3.681

2.  Beta 2 microglobulin in tear fluid from patients with primary Sjögren's syndrome.

Authors:  H M Markusse; J C Huysen; E J Nieuwenhuys; A J Swaak
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

3.  Emotional approach coping in older adults as predictor of physical and mental health.

Authors:  Michael A Hoyt; Ashley Wei-Ting Wang; Ian A Boggero; Tory A Eisenlohr-Moul; Annette L Stanton; Suzanne C Segerstrom
Journal:  Psychol Aging       Date:  2020-04-09

4.  Task-switching ability protects against the adverse effects of pain on health: A longitudinal study of older adults.

Authors:  Ian A Boggero; Tory Eisenlohr-Moul; Suzanne C Segerstrom
Journal:  Br J Health Psychol       Date:  2015-12-20

5.  Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and beta-2-microglobulin in Sjögren's syndrome.

Authors:  J Krejsek; R Slezák; O Kopecky; V Derner; C Andrys
Journal:  Clin Rheumatol       Date:  1997-03       Impact factor: 2.980

Review 6.  Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development.

Authors:  Leonie van Meer; Matthijs Moerland; Adam F Cohen; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

7.  Soluble CD22 as a tumor marker for hairy cell leukemia.

Authors:  Kakushi Matsushita; Inger Margulies; Masanori Onda; Satoshi Nagata; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Blood       Date:  2008-07-02       Impact factor: 22.113

8.  Tumour markers: An overview.

Authors:  T Malati
Journal:  Indian J Clin Biochem       Date:  2007-09

9.  Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease.

Authors:  Kuninobu Wakabayashi; Shigeko Inokuma; Erika Matsubara; Kae Onishi; Hiromitsu Asashima; Shinichiro Nakachi; Kiyofumi Hagiwara
Journal:  Clin Rheumatol       Date:  2013-03-16       Impact factor: 2.980

10.  The diagnostic value of salivary fluid levels of beta 2-microglobulin, lysozyme and lactoferrin for primary Sjögren's syndrome.

Authors:  H M Markusse; H G Otten; T M Vroom; T J Smeets; N Fokkens; F C Breedveld
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.